Janssen, Bayer Say It Is Time To End Fluoroquinolone MDL
MINNEAPOLIS — The Janssen and Bayer defendants named in the fluoroquinolone multidistrict litigation asked the court to terminate the MDL, arguing that the MDL “has fulfilled its original purpose and that...To view the full article, register now.
Already a subscriber? Click here to view full article